<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Is Autoimmune Thrombocytopenia Itself the Primary Disease in the Presence of Second Diseases? Data from a Long-Term Observation</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-10-18">October 18, 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Nasra</forename><surname>Aboud</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Transfusion Medicine</orgName>
								<orgName type="institution">Charité Unversitätsmedizin Berlin</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Fabian</forename><surname>Depré</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Transfusion Medicine</orgName>
								<orgName type="institution">Charité Unversitätsmedizin Berlin</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology and Pneumology</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Abdulgabar</forename><surname>Salama</surname></persName>
							<email>abdulgabar.salama@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Institute of Transfusion Medicine</orgName>
								<orgName type="institution">Charité Unversitätsmedizin Berlin</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>Prof. Dr. med</roleName><forename type="middle">Abdulgabar</forename><surname>Salama</surname></persName>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="institution">Institut für Transfusionsmedizin Charité Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Augustenburger Platz 1</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Is Autoimmune Thrombocytopenia Itself the Primary Disease in the Presence of Second Diseases? Data from a Long-Term Observation</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-10-18">October 18, 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">07B824F636C9E54DEB87A1B97A8B2F70</idno>
					<idno type="DOI">10.1159/000449038</idno>
					<note type="submission">Received: March 2, 2016 Accepted: August 1, 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:13+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Autoimmune thrombocytopenia (ITP) is one of the best characterized autoimmune diseases.</s><s>Based on clinical and laboratory findings, it is classified into primary (idiopathic) and secondary forms.</s><s>While the primary form is defined as an isolated disease, the secondary form is associated with at least one underlying disease/ abnormality <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref>.</s></p><p><s>In general, it is accepted that approximately 80% of ITP patients suffer from the primary form and the remaining patients have a secondary form.</s><s>The diseases associated with the secondary form include lupus erythematosus (5%), infections e.g., HCV, HIV, and Helicobacter pylori (6%), post-vaccination syndrome (1%), antiphospholipid syndrome (2%), lymphoma (2%) and Evans syndrome (2%) <ref type="bibr" target="#b5">[6]</ref>.</s><s>However, a systematic analysis of the incidence of secondary ITP is lacking <ref type="bibr" target="#b5">[6]</ref>.</s><s>Ultimately, data available thus far are largely based on the diagnosis at first presentation without systemic assessment of affected patients.</s><s>In addition, it may take months or even years until the clinical manifestation of the associated disease becomes obvious, e.g., malignancies.</s><s>Finally, the causa tive primary underlying disease/abnormality may remain unrecognized in asymptomatic patients, e.g., in those with clinically inconspicuous antibody deficiency.</s><s>Thus, the incidences of 'true' primary or secondary ITP are not only speculative, but also arbitrary in many cases.</s></p><p><s>In this study, we re-examined the diagnoses in patients with chronic ITP (&gt;1 year), since we observed that many patients had developed or had yet unrecognized relevant diseases and/or abnormalities which appeared to play a role in the pathogenesis of ITP.</s><s>In addition, there is evidence that ITP itself might be a predisposing factor for the development of some other diseases.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Keywords</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Autoimmune thrombocytopenia • Secondary autoimmune thrombocytopenia • Evans syndrome • Antibody deficiency syndrome • Platelets</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Summary</head><p><s>Background: Dependent on the absence or presence of associated diseases, autoimmune thrombocytopenia (ITP) can be classified as primary or secondary form.</s><s>The manifestation of the associated diseases is not temporally defined and may occur during observation.</s><s>Thus the question which disease is the primary one remains unanswered.</s><s>Methods: All 386 patients included in this study were treated by a single primary physician between 1996 and 2015 at the Charité Berlin and met current ITP criteria.</s><s>Medical records and investigations were reviewed to assess diseases associated with ITP.</s><s>Results: Initially, the vast majority of patients presented with primary ITP (isolated disease).</s><s>Based on our findings, ITP was found to be associated with other abnormalities in most cases.</s><s>These abnormalities included: positive direct antiglobulin test in 49 of 386 tested patients (13%), affections of the thyroid gland in 41 of 386 tested patients (11%), infections in 30 (8%), solid malignancies in 20 (5%) and hematological malignancies in 10 patients (3%), as well as many other miscellaneous diseases.</s><s>Moreover, of 160 patients who did not receive prior intravenous immunoglobulin treatment, 40 (25%) showed antibody deficiency.</s><s>Conclusion: In conclusion, the incidence of 'true' ITP as a primary disease is less common than has yet been suggested.</s><s>Additionally, there is evidence that ITP itself predispose affected subjects toward development of other diseases.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients and Methods</head><p><s>All 386 patients in this study (132 male, 254 female; age: 3-101 years, mean: 51 years) met chronic ITP criteria <ref type="bibr" target="#b2">[3]</ref>.</s><s>The diagnosis of ITP was first made between 1959 and 2015 (mean 2005).</s><s>All patients were treated on an outpatient basis by a single physician between 1996 and 2015 at the Institute of Transfusion Medicine of the Charité -Universitätsmedizin Berlin, Germany.</s><s>All medical records and investigations were reviewed retrospectively to assess possible causes of ITP.</s><s>Serum and platelets, if available in a sufficient amount during an active phase of the ITP, were investigated by the indirect and direct monoclonal antibody-specific immobilization of platelet antigen assay (MAIPA) as described by Meyer et al. <ref type="bibr" target="#b6">[7]</ref>.</s><s>Serological testing of red blood cells (RBCs) was performed in all patients using the standard gel technique.</s><s>The presence of "true" RBC autoantibodies was confirmed by testing the eluate of patients' RBCs <ref type="bibr" target="#b7">[8]</ref>.</s><s>The concentrations of IgG, IgA, and IgM were measured in 160 patients using rate nephelometry (Beckman Coulter, Krefeld, Germany) and ELISA (IMTEC Immundiagnostika, Berlin, Germany).</s><s>Immunoglobulins were not measured in patients who had recently received intravenous immunoglobulin (IVIG) treatment.</s><s>Similarly, free T 3 (triiodothyronine), T 4 (thyroxine), and TSH (thyroid-stimulating hormone) were tested in patients who were not under treatment with thyroid or antithyroid drugs.</s><s>If indicated, additional parameters, e.g.</s><s>antinuclear autoantibodies (ANA), rheumatoid factors (RF), anti-double stranded DNA and anti-viral hepatitis antibodies were also tested.</s><s>This study was approved by the institutional ethic review board (EA2/058112).</s><s>Informed consent was obtained from all patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>According to the criteria previously defined <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref>, at least 222 (58%) of the 386 patients included appeared to have a secondary rather than a primary ITP (table <ref type="table" target="#tab_0">1</ref>).</s><s>The most common associated disorder was autoimmunization against RBCs, with 49 of 386 patients (13%) being tested positive by the direct anti-human globulin test (DAT).</s><s>Other common associated diseases were antibody deficiency in 40 of 160 patients (25%), affection of the thyroid gland in 41 of 386 patients (11%), and infections in 30 of 386 patients (8%) (tables 1, 2).</s><s>Other diseases and abnormalities included solid malignancies, hematological malignancies, psoriasis, rheumatoid arthritis, collagenoses (tables 1, 2), and other miscellaneous diseases (table <ref type="table" target="#tab_3">3</ref>).</s><s>We considered a possible association between ITP and a second disease only if both diseases were present at the same time or the relationship between the diseases was wellknown, e.g.</s><s>solid malignancies or autoimmune diseases.</s><s>Most importantly, the association with other diseases/abnormalities could not be made during the first investigation and/or only became obvious during further observation.</s><s>In addition, the abnormalities as- ITP was the first manifestation, later followed by other diseases/ abnormalities.</s><s>In others, the reverse was true.</s><s>For example, 4 of 6 patients with breast cancer were first diagnosed with ITP and only later to suffer from breast cancer, while the other 2 were first diagnosed with breast cancer and then developed ITP.</s><s>Similarly, 4 of 10 patients with hematological malignancies developed ITP before the malignancy could be detected, whereas 6 were first diagnosed with hematological malignancies and later with ITP.</s><s>Of 11 patients suffering from psoriasis, 7 were diagnosed with ITP at a later point while 4 received ITP as primary and psoriasis as secondary diagnosis.</s><s>Similarly, 3 of 5 patients with multiple sclerosis developed ITP, and 2 patients with ITP developed multiple sclerosis during the observation period.</s><s>In addition, we believe some other patients may have had asymptomatic multiple sclerosis.</s><s>Eight of 11 patients appeared to have developed lupus erythematosus prior to the manifestation of ITP.</s><s>Finally, it cannot be predicted whether or not other patients with 'true' ITP will develop secondary diseases during further observation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>In this study, we focused on the occurrence and/or presence of secondary diseases and abnormalities in patients with chronic ITP.</s><s>At first glance, the majority of these patients appeared to have isolated ITP.</s><s>Similar to other studies dealing with long-term outcomes of patients with chronic ITP, our observations show that many affected patients developed a second disease as a complication of ITP <ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref>.</s><s>Together, these findings reflect different etiologic observations which should be considered in further studies.</s></p><p><s>Firstly, the current ITP classification into primary and secondary types is not reliable and in many cases inaccurate.</s><s>At least 58% (n = 222) of our patients with ITP exhibited other abnormalities Most intriguingly, there was no clear sequence regarding the occurrence of ITP and other diseases/abnormalities.</s><s>In some cases, with or without clinical manifestation, e.g., DAT positivity, antibody deficiency, malignancies, or other diseases and abnormalities (table <ref type="table" target="#tab_0">1</ref>).</s></p><p><s>Secondly, the prevailing concept in ITP diagnosis considers the associated disease as the primary one.</s><s>This might be the case in many but not in all instances.</s><s>In some cases, ITP itself might be responsible for the development of associated diseases.</s><s>This is supported by the fact that the manifestation of ITP may sometimes occur a long time prior to the manifestation of the associated disease.</s><s>However, a true association between ITP and other diseases cannot be proven invariably due to the long period of time between occurrence and manifestation and/or diagnosis of the diseases.</s></p><p><s>In case of Evans syndrome, both cytopenias may occur simultaneously, the ITP may precede the onset of the autoimmune hemolytic anemia (AIHA) or vice versa.</s><s>In the latter case, the interval between the manifestations of both cytopenias varies between several months and several years <ref type="bibr" target="#b13">[14]</ref>.</s><s>In addition, autoimmune neutropenia may occur in association with AIHA and/or ITP.</s><s>However, the true incidence of these associations remains obscure due to the fact that the majority of the affected patients require treatment, e.g.</s><s>steroids, to prevent the manifestation of a second cytopenia.</s><s>Ultimately and in agreement with the first description of Evans and Duane <ref type="bibr" target="#b14">[15]</ref>, the autoantibodies to RBCs do not invariably cause hemolysis, and the affected patients may only suffer from ITP and/or neutropenia.</s><s>Similarly, malignancies are a product of a complicated process that may halt several years until the disease becomes evident.</s><s>Thus, it is impossible to determine when the primary tumor first developed and when the onset of tumor-associated dysregulation occurred for the first time.</s><s>Since platelets are also involved in the process of malignancies <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b16">17]</ref>, it remains unclear which disease is the primary and which is the secondary one.</s><s>Recently, we identified many differentially expressed oncoproteins and tumor suppressor proteins in ITP <ref type="bibr" target="#b17">[18]</ref>.</s><s>This finding supports the hypothesis of an interaction between platelets and many malignancies <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b16">17]</ref>.</s></p><p><s>The results of MAIPA were inconclusive since the direct test could not be performed in patients with very low platelet counts.</s><s>In addition, the results were dependent on platelet count and the type of therapy the patients received.</s><s>The autoantibodies may disappear or remain undetectable when platelet counts increase to 50 × 10 9 /l (e.g., following treatment with steroids), or they may remain detectable even when the ITP enters into complete remission (e.g., following splenectomy).</s></p><p><s>There is no doubt that platelets play a key role in the immune continuum, including the release of various chemokines, cytokines, and many other mediators.</s><s>Platelets are known to directly interact or to mediate interaction with all or nearly all immune cells <ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref>.</s><s>Moreover, we have recently identified a large number of differentially expressed proteins in ITP.</s><s>In addition to oncoproteins and tumor suppressor proteins, several specific autoantibodies occurring in other autoimmune diseases were also detectable in ITP <ref type="bibr" target="#b17">[18]</ref>.</s><s>Thus, the supposition cannot be dismissed that ITP might be the primary disease stimulating the development of other diseases (including malignancies and other autoimmune diseases or phenomena).</s><s>However, it cannot be excluded that the associated diseases frequently induce the development of ITP, even in cases where ITP occurs prior to the manifestation of the primary disease.</s><s>Whatever the primary disease may be, there is ample evidence that a reciprocal influence exists between ITP and associated diseases.</s><s>It is beyond the scope of this study to highlight the biology of plate- lets in the immune continuum, but we must update our historic viewpoint on this subject.</s><s>Platelets are not only essential to hemostasis but also actively participate in immunity.</s><s>Meanwhile, more than 1,000 proteins, of which 69 are membrane proteins, have been shown to be associated with platelets, and a large number of these molecules play a role in immune processes <ref type="bibr" target="#b22">[23,</ref><ref type="bibr" target="#b23">24]</ref>.</s><s>This is supported by a number of clinical findings such as the significant correlation of fatigue and 'pseudoarthritis' in ITP with low platelet counts <ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref>.</s></p><p><s>In both cases, the affected patients frequently attribute their repeated suffering from tiredness and/or joint pains to having low platelet counts.</s><s>These symptoms, however, cannot be explained bylow platelet count alone but rather by an unrecognized interaction of platelets or their contents with other regulatory cells and cell receptors.</s><s>Finally, serotonin has been shown to be involved in fatigue syndrome <ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref> and different forms of immune-mediated arthritis <ref type="bibr" target="#b33">[34]</ref>, and platelets are the main carriers for serotonin <ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref>.</s><s>A previous study showed that neuropharmacological treatment resulted in an increase of platelet counts in at least 5 patients suffering from ITP <ref type="bibr" target="#b37">[38]</ref>.</s><s>Moreover, platelets have been shown to be implicated in several autoimmune conditions, including lupus erythematosus, rheumatoid arthritis, sclerodermatitis, and multiple sclerosis <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b38">[39]</ref><ref type="bibr" target="#b39">[40]</ref><ref type="bibr" target="#b40">[41]</ref>.</s></p><p><s>We are aware of the limitations of the present study, which are mainly due to its retrospective character.</s><s>In addition, the number of ITP patients with associated hematological malignancies is inadequately represented due to the fact that we did not treat patients primarily suffering from malignancies, e.g.</s><s>lymphoma.</s><s>Thus, new sophisticated studies are required to gain deeper insights into the interactions and causal relationships of ITP with other diseases.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Patients with significant and/or insignificant underlying disease/abnormality that may be causative for ITP or vice versa</s></p></div></figDesc><table><row><cell>Underlying disease/</cell><cell>Patients with one relevant</cell><cell>Patients with one additional</cell><cell>Patients with two additional</cell><cell>Patients with three additional</cell></row><row><cell>abnormality</cell><cell>underlying disease</cell><cell>relevant underlying disease/</cell><cell>relevant underlying diseases/</cell><cell>relevant underlying diseases/</cell></row><row><cell></cell><cell>/abnormality (n)</cell><cell>abnormality (n)</cell><cell>abnormalities (n)</cell><cell>abnormalities (n)</cell></row><row><cell>Evans syndrome</cell><cell>22</cell><cell>6× AD, 4× TG,</cell><cell>2× AD + TG, 1× drug-</cell><cell>1× COLL + APS + TG</cell></row><row><cell></cell><cell></cell><cell>4× COLL, 2× INF, 1× APS,</cell><cell>induced + INF, 1× MS +</cell><cell></cell></row><row><cell></cell><cell></cell><cell>1× HPC, 1× PS</cell><cell>APS, 1× COLL + R.A.,</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>1× HM + AD, 1× AD + PS</cell><cell></cell></row><row><cell>Antibody deficiency</cell><cell>19</cell><cell>4× TG, 2× INF, 1× COLL,</cell><cell>1× MS + suspicion of</cell><cell>1× PS + R.A. + TG</cell></row><row><cell></cell><cell></cell><cell>1× solid malignancy</cell><cell>drug-induced, 1× solid</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>malignancy + suspicion of</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>drug-induced</cell><cell></cell></row><row><cell>Solid malignancy</cell><cell>14</cell><cell>1× suspicion of drug-</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>induced, 1× PS, 1× INF,</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>1× TG</cell><cell></cell><cell></cell></row><row><cell>Infection</cell><cell>15</cell><cell>4× HPC, 3× drug-induced,</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>1× HM, 1× TG</cell><cell></cell><cell></cell></row><row><cell>Affection of the thyroid gland</cell><cell>25</cell><cell>1 × COLL</cell><cell>1 APS + COLL</cell><cell></cell></row><row><cell>Rheumatoid arthritis</cell><cell>8</cell><cell>1× COLL</cell><cell>1× PBC + COLL,</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>1× MDS + INF</cell><cell></cell></row><row><cell>Hematological malignancies</cell><cell>7</cell><cell>1× MDS</cell><cell></cell><cell></cell></row><row><cell>Suspicion to be drug-induced</cell><cell>7</cell><cell></cell><cell>1× APS + COLL</cell><cell></cell></row><row><cell>Psoriasis</cell><cell>6</cell><cell>1× HPC</cell><cell></cell><cell></cell></row><row><cell>Collagenosis</cell><cell>4</cell><cell>1× Sneddon syndrome</cell><cell></cell><cell></cell></row><row><cell>Miscellaneous diseases</cell><cell>33</cell><cell>2</cell><cell></cell><cell></cell></row><row><cell>Total patients</cell><cell>160</cell><cell>47</cell><cell>13</cell><cell>2</cell></row></table><note><p><s>AD = Antibody deficiency; APS = antiphospholipide syndrome; COLL = collagenosis; Evans = Evans syndrome; HM = hematological malignancies; HPC = hepatic cirrhosis; IBD = inflammatory bowel disease; INF = infection; MDS = myelodysplastic syndrome; MS = multiple sclerosis; PBC = primary biliary cirrhosis; PS = psoriasis; R.A. = rheumatoid arthritis; TG = affection of thyroid gland.</s><s>Is Autoimmune Thrombocytopenia Itself the Primary Disease in the Presence of Second Diseases?</s><s>Data from a Long-Term Observation Transfus Med Hemother 2017;44:23-28 25</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Character of diseases/abnormalities associated to ITP</s></p></div></figDesc><table><row><cell>Patients (n)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Continued</s></p></div></figDesc><table><row><cell>sociated with the ITP were often asymptomatic and without clini-</cell></row><row><cell>cal significance. Only 17 of 49 (35%) patients with detectable au-</cell></row><row><cell>toantibodies to RBCs had or developed significant hemolysis, and 4</cell></row><row><cell>of 40 (10%) patients with antibody deficiency had significant dis-</cell></row><row><cell>position to infection and required IgG substitutions. In contrast,</cell></row><row><cell>the vast majority of patients with thyroid diseases required treat-</cell></row><row><cell>ment with thyroid hormones.</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3 .</head><label>3</label><figDesc><div><p><s>Character of miscellaneous diseases that may be causative for ITP or vice versa</s></p></div></figDesc><table><row><cell>Underlying diseases/abnormalities</cell><cell>Patients (n)</cell></row><row><cell>Drug-induced</cell><cell>5</cell></row><row><cell>MDS</cell><cell>4</cell></row><row><cell>PBC</cell><cell>3</cell></row><row><cell>IBD (1× Morbus Crohn; 2× colitis ulcerosa)</cell><cell>3</cell></row><row><cell>Anti-TPO</cell><cell>3</cell></row><row><cell>MS</cell><cell>3</cell></row><row><cell>APS</cell><cell>2</cell></row><row><cell>HPC</cell><cell>2</cell></row><row><cell>Thymom</cell><cell>2</cell></row><row><cell>Coomb's-negative hemolytic anemia</cell><cell>1</cell></row><row><cell>Polymyalgia rheumatica</cell><cell>1</cell></row><row><cell>Hip implant-induced</cell><cell>1</cell></row><row><cell>Pituitary adenoma</cell><cell>1</cell></row><row><cell>Sneddon's syndrome</cell><cell>1</cell></row><row><cell>Sneddon's syndrome + APS</cell><cell>1</cell></row><row><cell>Sarcoidosis</cell><cell>1</cell></row><row><cell>Elevated ANA + amalgam (remission after detoxification)</cell><cell>1</cell></row><row><cell>Total</cell><cell>35</cell></row><row><cell cols="2">Anti-TPO = Thyroid peroxidase antibody; APS = antiphospholipide syndrome; HPC = hepatic cirrhosis;</cell></row><row><cell cols="2">IBD = inflammatory bowel disease; MDS = myelodysplastic syndrome; MS = multiple sclerosis;</cell></row><row><cell>PBC = primary biliary cirrhosis.</cell><cell></cell></row></table><note><p><s>Is Autoimmune Thrombocytopenia Itself the Primary Disease in the Presence of Second Diseases?</s><s>Data from a Long-Term Observation Transfus Med Hemother 2017;44:23-28 27</s></p></note></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosure Statement</head><p><s>All authors declare that they have no conflict of interests due to sponsorship or funding arrangements related to this study.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Secondary immune thrombocytopenic purpura</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Liebman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Stasi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Hematol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="557" to="573" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Heterogenity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from a systematic review of the literature</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ruggeri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fortuna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Rodeghiero</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="98" to="103" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group</title>
		<author>
			<persName><forename type="first">F</forename><surname>Rodeghiero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Stasi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gernsheimer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Michel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Provan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Arnold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Bussel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Cines</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Chong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Godeau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lechner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Mazzucconi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mcmillan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Sanz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Imbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Blanchette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kühne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ruggeri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>George</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="2386" to="2393" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Definition, diagnosis and treatment of immune thrombocytopenic purpura</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>George</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="759" to="762" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">International consensus report on the investigation and management of primary immune thrombocytopenia</title>
		<author>
			<persName><forename type="first">D</forename><surname>Provan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Stasi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Newland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">S</forename><surname>Blanchette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bolton-Maggs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Bussel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Chong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Cines</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Gernsheimer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Godeau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Grainger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Greer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Hunt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Imbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lyons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mcmillan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Rodeghiero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Sanz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tarantino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Watson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Kuter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="168" to="186" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">The ITP syndrome: pathogenetic and clinical diversity</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Cines</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Bussel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Liebman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Luning</forename><surname>Prak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">T</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="6511" to="6521" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">A novel antigen-specific capture assay for the detection of platelet antibodies and HPA-1a phenotyping</title>
		<author>
			<persName><forename type="first">O</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Agaylan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bombard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kiesewetter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Salama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vox Sang</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="324" to="330" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Chameleonic&apos; serological findings leading to lifethreatening hemolytic transfusion reactions</title>
		<author>
			<persName><forename type="first">A</forename><surname>Sümnig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Mayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Kiefel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Greinacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Salama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Transfus Med Hemother</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="340" to="343" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Djulbegovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Shamai-Lubovitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Mozes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="page" from="1630" to="1638" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Morbidity and mortality in adults with idiopathic thrombocytopenic purpura</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Portielje</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Westendorp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Kluin-Nelemans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brand</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="2549" to="2554" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Comorbidities of idiopathic thrombocytopenic purpura: a population-based study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Feudjo-Tepie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Le</forename><surname>Roux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Beach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Robinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Hematol</title>
		<imprint>
			<biblScope unit="page">963506</biblScope>
			<date type="published" when="2009">2009. 2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Comorbidities in patients with persistent or chronic immune thrombocytopenia</title>
		<author>
			<persName><forename type="first">C</forename><surname>Enger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Forssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Fogarty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Mcafee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Hematol</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="289" to="295" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Longterm clinical outcomes of patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nørgaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Ø</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Engebjerg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Farkas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Thomsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Sørensen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="3514" to="3520" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases</title>
		<author>
			<persName><forename type="first">M</forename><surname>Michel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Chanet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dechartres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Morin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Piette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cirasino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Emilia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Zaja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ruggeri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Andrès</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bierling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Godeau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Rodeghiero</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="3167" to="3172" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Acquired hemolytic anemia; the relation of erythrocyte antibody production to activity of the disease; the significance of thrombocytopenia and leukopenia</title>
		<author>
			<persName><forename type="first">R</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Duane</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="1196" to="1213" />
			<date type="published" when="1949">1949</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">The role of platelets in the tumor microenvironment: from solid tumors to leukemia</title>
		<author>
			<persName><forename type="first">M</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Jurasz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1863</biblScope>
			<biblScope unit="page" from="392" to="400" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Involvement of platelets in tumor cell metastasis</title>
		<author>
			<persName><forename type="first">B</forename><surname>Tesfamariam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacol Ther</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="page" from="112" to="119" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Identification of novel biomarkers in chronic immune thrombocytopenia (ITP) by microarray-based serum protein profiling</title>
		<author>
			<persName><forename type="first">G</forename><surname>Bal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Futschik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hartl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ringel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kamhieh-Milz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Sterzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Hoheisel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Alhamdani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Salama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Haematol</title>
		<imprint>
			<biblScope unit="volume">172</biblScope>
			<biblScope unit="page" from="602" to="615" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Platelets: signaling cells in the immune continuum</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Weyrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Zimmerman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Immunol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="489" to="495" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Platelets and the immune continuum</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Semple</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Italiano</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Freedman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="264" to="274" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Bench-to-bedside review: platelets and active immune functions -new clues for immunopathology?</title>
		<author>
			<persName><forename type="first">O</forename><surname>Garraud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hamzeh-Cognasse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Pozzetto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Cavaillon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cognasse</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">236</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Regulation of the genetic code in megakaryocytes and platelets</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Rondina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Weyrich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Thromb Haemost</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="26" to="32" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Deciphering the human platelet sheddome</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Fong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Barry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Tran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Traxler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Wannemacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Speicher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">A</forename><surname>Blair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Speicher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Grosser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Brass</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="15" to="26" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Emerging roles for platelets as immune and inflammatory cells</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Morrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Aggrey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Chapman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Modjeski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="2759" to="2767" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Fatigue in adult patients with primary immune thrombocytopenia</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Newton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Reese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Watson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Vesely</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Bolton-Maggs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>George</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Terrell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Haematol</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="420" to="429" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Fatigue in immune thrombocytopenia</title>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">A</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Newland</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Haematol</title>
		<imprint>
			<biblScope unit="volume">170</biblScope>
			<biblScope unit="page" from="141" to="149" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Advances in ITP -therapy and quality of life -a patient survey</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Matzdorff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Arnold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Salama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ostermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Eberle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hummler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">27350</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Fatigue as marker of thrombocytopenia in childhood idiopathic thrombocytopenic purpura</title>
		<author>
			<persName><forename type="first">J</forename><surname>Blatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Weston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gold</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Hematol Oncol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="65" to="67" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Thrombopoietin receptor agonists are often ineffective in immune thrombocytopenia and/or cause adverse reactions: results from one hand</title>
		<author>
			<persName><forename type="first">F</forename><surname>Depré</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Aboud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ringel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Salama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Transfus Med Hemother</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="375" to="379" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Tryptophan depletion in chronic fatigue syndrome, a pilot cross-over study</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>The</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Verkes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fekkes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bleijenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Van Der Meer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Buitelaar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Res Notes</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">650</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Reduction of serotonin transporters of patients with chronic fatigue syndrome</title>
		<author>
			<persName><forename type="first">S</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ouchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Onoe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Yoshikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tsukada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Iwase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yamaguti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kuratsune</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Watanabe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroreport</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="2571" to="2574" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Chronic fatigue syndrome: a review</title>
		<author>
			<persName><forename type="first">N</forename><surname>Afari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Buchwald</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="page" from="221" to="236" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Association between serotonin transporter gene polymorphism and chronic fatigue syndrome</title>
		<author>
			<persName><forename type="first">M</forename><surname>Narita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Nishigami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Narita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yamaguti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Okado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kuratsune</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="264" to="266" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Decreased density of serotonin 5-HT2A receptors in rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rantapää-Dahlqvist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Stenlund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mjörndal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="816" to="819" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">The measurement of plateletpoor plasma serotonin: a systematic review of prior reports and recommendations for improved analysis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Brand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Anderson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="1376" to="1386" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Transporters in human platelets: physiologic function and impact for pharmacotherapy</title>
		<author>
			<persName><forename type="first">G</forename><surname>Jedlitschky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Greinacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Kroemer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="3394" to="3402" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Flow cytometry detection of serotonin content and release in resting and activated platelets</title>
		<author>
			<persName><forename type="first">G</forename><surname>Gobbi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mirandola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Tazzari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ricci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Caimi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cacchioli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Papa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Conte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vitale</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Haematol</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="892" to="896" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Neuropharmacological treatment of refractory idiopathic thrombocytopenic purpura: roles of circulating catecholamines and serotonin</title>
		<author>
			<persName><forename type="first">F</forename><surname>Lechin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Van Der Dijs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Orozco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Jahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Baez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thromb Haemost</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="1254" to="1256" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with chronic fatigue syndrome</title>
		<author>
			<persName><forename type="first">M</forename><surname>Loebel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Grabowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Heidecke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Hanitsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wittke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Meisel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Reinke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">D</forename><surname>Volk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ø</forename><surname>Fluge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Mella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Scheibenbogen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Behav Immun</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="32" to="39" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Platelets: active players in the pathogenesis of arthritis and SLE</title>
		<author>
			<persName><forename type="first">E</forename><surname>Boilard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Blanco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Nigrovic</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Rheumatol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="534" to="542" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Toes RE: Platelets and autoimmunity</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Habets</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Huizinga</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="746" to="757" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
